Moldova - rumensk - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

balkan pharmaceuticals srl, sc - exemestanum - comprimate - 25 mg

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - exemestanum - compresse rivestite - exemestanum 25 mg, mannitolum, hypromellosum, polysorbatum 80, crospovidonum, silica colloidalis hydrica, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum, simeticonum, macrogolum 6000, magnesii subcarbonas levis, e 171, e 218 0.003 mg, poly(alcohol vinylicus), saccharum 30.19 mg, cetaceum syntheticum, talcum, cera carnauba, drucktinte: lacca, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, pro compresso obducto corresp. natrium 0.1 mg. - carcinoma della mammella - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - exemestanum - compresse rivestite con film - exemestanum 25 mg, mannitolum, cellulosum microcristallinum, crospovidonum typ a, carboxymethylamylum natricum a corresp. natrium 0.29 - 0.44 mg, hypromellosum, polysorbatum 80, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - 2nd e 3rd line terapia avanzata di mamma-ca nelle pazienti in postmenopausa - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - exemestanum - compresse rivestite con film - exemestanum 25 mg, mannitolum, hypromellosum, crospovidonum, polysorbatum 80, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, silica colloidalis anhydrica, Überzug: carmellosum natricum, maltodextrinum, glucosum monohydricum 0.441 mg, acidum stearicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.15 - 0.25 mg. - 2nd e 3rd line terapia avanzata di mamma-ca nelle pazienti in postmenopausa - synthetika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - exemestanum - überzogene tabletten - exemestanum 25 mg, mannitolum, hypromellosum, polysorbatum 80, crospovidonum, silica colloidalis hydrica, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum, simeticonum, macrogolum 6000, magnesii subcarbonas levis, e 171, e 218 0.003 mg, poly(alcohol vinylicus), saccharum 30.19 mg, cetaceum syntheticum, talcum, cera carnauba, drucktinte: lacca, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, pro compresso obducto corresp. natrium 0.1 mg. - mammakarzinom - synthetika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - exemestanum - filmtabletten - exemestanum 25 mg, mannitolum, cellulosum microcristallinum, crospovidonum typ a, carboxymethylamylum natricum a corresp. natrium 0.29 - 0.44 mg, hypromellosum, polysorbatum 80, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - 2nd und 3rd line therapie des fortgeschrittenen mamma-ca bei postmenopausalen patientinnen - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - exemestanum - comprimés enrobés - exemestanum 25 mg, mannitolum, hypromellosum, polysorbatum 80, crospovidonum, silica colloidalis hydrica, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum, simeticonum, macrogolum 6000, magnesii subcarbonas levis, e 171, e 218 0.003 mg, poly(alcohol vinylicus), saccharum 30.19 mg, cetaceum syntheticum, talcum, cera carnauba, drucktinte: lacca, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, pro compresso obducto corresp. natrium 0.1 mg. - le cancer du sein - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - exemestanum - comprimés pelliculés - exemestanum 25 mg, mannitolum, cellulosum microcristallinum, crospovidonum typ a, carboxymethylamylum natricum a corresp. natrium 0.29 - 0.44 mg, hypromellosum, polysorbatum 80, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - 2ème et 3ème ligne de traitement du carcinome mammaire-ca, post-ménopausique chez les patientes - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - exemestanum - comprimés pelliculés - exemestanum 25 mg, mannitolum, hypromellosum, crospovidonum, polysorbatum 80, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, silica colloidalis anhydrica, Überzug: carmellosum natricum, maltodextrinum, glucosum monohydricum 0.441 mg, acidum stearicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.15 - 0.25 mg. - 2ème et 3ème ligne de traitement du carcinome mammaire-ca, post-ménopausique chez les patientes - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - exemestanum - comprimés pelliculés - exemestanum 25 mg, mannitolum, crospovidonum, carboxymethylamylum natricum a corresp. natrium 0.1 mg, hypromellosum, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171 pro compresso obducto. - 2ème et 3ème ligne de traitement du carcinome mammaire-ca, post-ménopausique chez les patientes - synthetika